OP- 14 ENHANCED MUSCLE MASS MITIGATES MASLD IN MYOSTATIN KNOCKOUT MICE WITHOUT IMPACTING EXERCISE PERFORMANCE Daniel Cabrera Garcia; Faride Saud Zapura; Loreto Aguilar Barria; Marco Arrese; Luis Antonio Díaz; Juan Pablo Arab; Lisbell Estrada; Claudio Cabello Verrugio; Francisco Barrera; Marcelo Andia;

OP-7 Further exploration of differences between lean and non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) in Latino subjects: PNPLA3 frequency and lipidomic profiles MARIA AYALA VALVERDE; Jorge Arnold Alvarez; Gustavo Ayares; Francisco Barrera; Daniel Cabrera; Luis Antonio Diaz; Juan Pablo Arab; Ibon Martinez-Arranz; Cristina Alonso; Jesús M. Bañales; Marco Arrese;

P- 53 NATURAL KILLER CELLS OF EARLY STAGES OF METABOLIC FATTY LIVER DISEASE PRESENT REDUCED CYTOTOXICITY AGAINST TUMOR CELLS. CASE- CONTROL ANALYSIS Nixa Paola Olivares; Daniel Ernst; Maria Cecilia Poli; Gustavo Pinto; Francisca Allendes; Vanessa Oyarzún; Nancy Solis; Marco Arrese; Juan Pablo Arab; Daniel Cabrera; Luis Antonio Diaz; Francisco Barrera;